EDP Sciences Journals List
Home Document
Subscriber Authentication Point
Free access article

Issue Math. Model. Nat. Phenom.
Volume 2, Number 3, 2007
Cancer modelling
Page(s) 47 - 68
DOI 10.1051/mmnp:2007003

Math. Model. Nat. Phenom. Vol. 2, No. 3, 2007, pp. 47-68
DOI: 10.1051/mmnp:2007003

Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement

Y. Kogan1, B. Ribba1, K. Marron1, N. Dahan2, V. Vainstein1 and Z. Agur1, 2

1  Institute for Medical Biomathematics (IMBM), POB 282 Hate'ena 10, Bene Ataroth, 60991 Israel
2  Optimata Ltd, 7 Abba Hillel Silver St., Ramat-Gan, 52522 Israel

agur@imbm.org

Abstract
Despite recent advances, treatment of patients with aggressive Non-Hodgkin's lymphoma (NHL2) has yet to be optimally designed. Notwithstanding the contribution of molecular treatments, intensification of chemotherapeutic regimens may still be beneficial. Hoping to aid in the design of intensified chemotherapy, we put forward a mathematical and computational model that analyses the effect of Doxorubicin on NHL over a wide range of patho-physiological conditions. The model represents tumour growth both in diffusion-limited settings, that is, in small avascular tumours and tumour cords, and in perfusion-limited settings, e.g. in well-vascularized tumours. Model simulations indicated the presence of a critical regimen intensity below which treatment will fall short of tumour elimination. Taking this critical intensity into account, we compared two regimen intensification strategies: Dose escalation and regimen densification, i.e. reducing the inter-dosing interval. In the diffusion-limited setting, dose escalation was somewhat more efficient than regimen densification. In the perfusion-limited setting, both intensification strategies yielded similar results. The present study coupled with a realistic myelotoxicity model may add insight on the optimisation of NHL intensified chemotherapy design.


Key words: mathematical model -- vascular tumour -- avascular tumour -- heterogeneity -- chemotherapy -- Non-Hodgkin Lymphoma -- CHOP -- Doxorubicin -- hybrid cellular automata




What is OpenURL?

The OpenURL standard is a protocol for transmission of metadata describing the resource that you wish to access. An OpenURL link contains article metadata and directs it to the OpenURL server of your choice. The OpenURL server can provide access to the resource and also offer complementary services (specific search engine, export of references...). The OpenURL link can be generated by different means.
  • If your librarian has set up your subscription with an OpenURL resolver, OpenURL links appear automatically on the abstract pages.
  • You can define your own OpenURL resolver with your EDPS Account. In this case your choice will be given priority over that of your library.
  • You can use an add-on for your browser (Firefox or I.E.) to display OpenURL links on a page (see http://www.openly.com/openurlref/). You should disable this module if you wish to use the OpenURL server that you or your library have defined.